Home
About
Pricing
Log In
Back
HMDN

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Heramed Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

N/A
Annual Growth

5 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

3
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Heramed Limited - Ordinary Fully Paid Deferred

๐Ÿ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in HMDN

0

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in HMDN

N/A
HMDN investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in HMDN also invest in...

Heramed Limited

HMD

HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-12-12. The firm is engaged in the digital transformation of maternity care by transforming the prenatal and postpartum experience with its hybrid maternity care platform. The firm offers a proprietary platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The HeraBEAT medical device is used by pregnant women in Europe, the United States, Israel and Australia. The Companyโ€™s proprietary offering, HeraCARE, is engineered to offer a fully integrated maternal health ecosystem designed to deliver care to ensure expectant mothers are engaged, informed and well-supported, allowing healthcare professionals to provide quality care and enable early detection and prevention of potential risks.

๐Ÿ™Œ Performance (5Yr p.a)

-14.67%

๐Ÿ“Š Share price

$0.04 AUD

๐Ÿฉบ HEALTH CARE

Find Out More

๐Ÿ“Š Share price

$0.04 AUD

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

18.13%

๐Ÿ“Š Share price

$154.83 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿค– TECHNOLOGY

๐ŸŒ GLOBAL

โ›ณ๏ธ DIVERSIFIED

Magellan Financial Group Ltd. engages in the provision of funds management services. The company is headquartered in Sydney, New South Wales and currently employs 111 full-time employees. The company went IPO on 2004-07-01. The Companyโ€™s segments include Funds Management, Fund Investments and Associate Investments. The Funds Management segment provides investment fund management services to high net worth and retail investors in Australia and New Zealand, and to institutional investors globally. Its Funds Management activities include providing investment research and administrative services to certain clients; providing investment management and sub-advisory services under client mandates, and acting as responsible entity/trustee (RE) and/or investment manager (IM) for the funds (collectively the Magellan Funds). The Fund Investments segment comprises its direct investment in certain Magellan Funds and a select portfolio of listed Australian and international equities. The Associate Investments segment comprises a portfolio of selective investments in businesses in which it has a strategic interest.

๐Ÿ™Œ Performance (5Yr p.a)

-16.79%

๐Ÿ“Š Share price

$9.63 AUD

๐Ÿ’ฐ HIGH DIVIDEND

๐Ÿ’ธ FINANCIALS

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

๐Ÿ™Œ Performance (5Yr p.a)

8.45%

๐Ÿ“Š Share price

$147.55 AUD

๐Ÿ’ธ FINANCIALS

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

๐Ÿ“ˆ HIGH PRICE GROWTH

โ›ณ๏ธ DIVERSIFIED

Want more shares? Try these...

๐Ÿ“Š Share price

$0.00 AUD

HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-12-12. The firm is engaged in the digital transformation of maternity care by transforming the prenatal and postpartum experience with its hybrid maternity care platform. The firm offers a proprietary platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The HeraBEAT medical device is used by pregnant women in Europe, the United States, Israel and Australia. The Companyโ€™s proprietary offering, HeraCARE, is engineered to offer a fully integrated maternal health ecosystem designed to deliver care to ensure expectant mothers are engaged, informed and well-supported, allowing healthcare professionals to provide quality care and enable early detection and prevention of potential risks.

๐Ÿ™Œ Performance (5Yr p.a)

-14.67%

๐Ÿ“Š Share price

$0.04 AUD

๐Ÿฉบ HEALTH CARE